Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-DNM3 antibody (410-555) (STJ117342) | Login | Anti-DNM3 antibody (410-555) (STJ117342) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLVCR1 antibody (250-350) (STJ117347) | Login | Anti-FLVCR1 antibody (250-350) (STJ117347) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAS2R10 antibody (100-200) (STJ117350) | Login | Anti-TAS2R10 antibody (100-200) (STJ117350) | ||||||||||||||||
|
||||||||||||||||||
Anti-RNF125 antibody (41-232) (STJ117359) | Login | Anti-RNF125 antibody (41-232) (STJ117359) | ||||||||||||||||
|
||||||||||||||||||
Anti-RNF125 antibody (1-105) (STJ117360) | Login | Anti-RNF125 antibody (1-105) (STJ117360) | ||||||||||||||||
|
||||||||||||||||||
Anti-HHAT antibody (1-100) (STJ117365) | Login | Anti-HHAT antibody (1-100) (STJ117365) | ||||||||||||||||
|
||||||||||||||||||
Anti-BAIAP2L1 antibody (1-300) (STJ117367) | Login | Anti-BAIAP2L1 antibody (1-300) (STJ117367) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFC antibody (166-345) (STJ117368) | Login | Anti-PDGFC antibody (166-345) (STJ117368) | ||||||||||||||||
|
||||||||||||||||||
Anti-EIF4ENIF1 antibody (150-250) (STJ117369) | Login | Anti-EIF4ENIF1 antibody (150-250) (STJ117369) | ||||||||||||||||
|
||||||||||||||||||
Anti-MMEL1 antibody (350-450) (STJ117382) | Login | Anti-MMEL1 antibody (350-450) (STJ117382) | ||||||||||||||||
|
||||||||||||||||||
Anti-ARL6 antibody (1-186) (STJ117392) | Login | Anti-ARL6 antibody (1-186) (STJ117392) | ||||||||||||||||
|
||||||||||||||||||
Anti-FAM83A antibody (1-160) (STJ117395) | Login | Anti-FAM83A antibody (1-160) (STJ117395) | ||||||||||||||||
|
||||||||||||||||||
Anti-QSOX2 antibody (370-650) (STJ117408) | Login | Anti-QSOX2 antibody (370-650) (STJ117408) | ||||||||||||||||
|
||||||||||||||||||
Anti-TCTN1 antibody (130-310) (STJ117127) | Login | Anti-TCTN1 antibody (130-310) (STJ117127) | ||||||||||||||||
|
||||||||||||||||||
Anti-TCTN1 antibody (130-310) (STJ117128) | Login | Anti-TCTN1 antibody (130-310) (STJ117128) | ||||||||||||||||
|
||||||||||||||||||
Anti-MATR3 antibody (747-847) (STJ117820) | Login | Anti-MATR3 antibody (747-847) (STJ117820) | ||||||||||||||||
|
||||||||||||||||||
Anti-AQR antibody (400-700) (STJ117823) | Login | Anti-AQR antibody (400-700) (STJ117823) | ||||||||||||||||
|
||||||||||||||||||
Anti-DCT antibody (50-350) (STJ117825) | Login | Anti-DCT antibody (50-350) (STJ117825) | ||||||||||||||||
|
||||||||||||||||||
Anti-BMX antibody (1-120) (STJ117827) | Login | Anti-BMX antibody (1-120) (STJ117827) | ||||||||||||||||
|
||||||||||||||||||
Anti-IL9R antibody (50-150) (STJ117828) | Login | Anti-IL9R antibody (50-150) (STJ117828) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPKAP1 antibody (360-522) (STJ117829) | Login | Anti-MAPKAP1 antibody (360-522) (STJ117829) | ||||||||||||||||
|
||||||||||||||||||
Anti-NMNAT1 antibody (1-150) (STJ117831) | Login | Anti-NMNAT1 antibody (1-150) (STJ117831) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDK16 antibody (277-496) (STJ117850) | Login | Anti-CDK16 antibody (277-496) (STJ117850) | ||||||||||||||||
|
||||||||||||||||||
Anti-NLRP2 antibody (665-820) (STJ117856) | Login | Anti-NLRP2 antibody (665-820) (STJ117856) | ||||||||||||||||
|
||||||||||||||||||
Anti-BAIAP2L1 antibody (198-388) (STJ117857) | Login | Anti-BAIAP2L1 antibody (198-388) (STJ117857) | ||||||||||||||||
|